- Home
- IVVD vs ABAT Comparison
IVVD vs ABAT Comparison
Compare IVVD & ABAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IVVD
- ABAT
- Stock Information
- Founded
- IVVD 2020
- ABAT 2011
- Country
- IVVD United States
- ABAT United States
- Employees
- IVVD N/A
- ABAT N/A
- Industry
- IVVD Biotechnology: Pharmaceutical Preparations
- ABAT Metal Mining
- Sector
- IVVD Health Care
- ABAT Basic Materials
- Exchange
- IVVD Nasdaq
- ABAT Nasdaq
- Market Cap
- IVVD 96.7M
- ABAT 87.2M
- IPO Year
- IVVD 2021
- ABAT N/A
- Fundamental
- Price
- IVVD $0.73
- ABAT $2.20
- Analyst Decision
- IVVD Strong Buy
- ABAT
- Analyst Count
- IVVD 3
- ABAT 0
- Target Price
- IVVD $5.85
- ABAT N/A
- AVG Volume (30 Days)
- IVVD 653.6K
- ABAT 7.7M
- Earning Date
- IVVD 08-13-2025
- ABAT 09-22-2025
- Dividend Yield
- IVVD N/A
- ABAT N/A
- EPS Growth
- IVVD N/A
- ABAT N/A
- EPS
- IVVD N/A
- ABAT N/A
- Revenue
- IVVD $36,688,000.00
- ABAT $1,857,877.00
- Revenue This Year
- IVVD $345.16
- ABAT $31,748.62
- Revenue Next Year
- IVVD $161.08
- ABAT N/A
- P/E Ratio
- IVVD N/A
- ABAT N/A
- Revenue Growth
- IVVD N/A
- ABAT N/A
- 52 Week Low
- IVVD $0.35
- ABAT $0.73
- 52 Week High
- IVVD $2.74
- ABAT $4.11
- Technical
- Relative Strength Index (RSI)
- IVVD 46.86
- ABAT 49.98
- Support Level
- IVVD $0.68
- ABAT $2.15
- Resistance Level
- IVVD $0.86
- ABAT $3.89
- Average True Range (ATR)
- IVVD 0.05
- ABAT 0.43
- MACD
- IVVD -0.00
- ABAT -0.07
- Stochastic Oscillator
- IVVD 36.09
- ABAT 24.55
About IVVD Invivyd Inc.
Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.
About ABAT American Battery Technology Company
American Battery Technology Co is engaged in lithium-ion battery recycling, battery metals and material extraction, and resource production. It is a battery metals company producing low-cost battery metals with a commitment to closed-loop, clean energy technologies.